We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nanosized Particles Found Near Plaque-Filled Arteries

By Biotechdaily staff writers
Posted on 08 May 2007
There is evidence of the presence of nanoparticles near plaque-filled arteries in animal models.

Scientific evidence increasingly links arterial calcification to the presence of nanosized particles so small that some scientists question whether a nanoparticle can live, and if so, play a viable role in causing disease.

A new Mayo Clinic (Rochester, MI, USA) study suggests that nanoparticles potentially represent a previously unrecognized factor in the development of arteriosclerosis and calcific arterial disease. The study was presented during the 2007 Experimental Biology meeting in Washington, DC (USA) on April 29,2007.

Calcium deposits clog blood vessels and damage major organs, such as the heart. But the molecular mechanisms that kick-start this process, called pathologic calcification, have not been explained. The study's author, a Mayo Clinic graduate student, Maria Kraemer, and colleagues isolated and propagated self-replicating, self-calcifying nanoparticles from human arteriosclerotic aneurysms and kidney stones.

"The work we are doing with human-derived nanoparticles is important because preliminary studies indicate that they may increase negative responses to arterial injury, possibly leading to blocked arteries and arterial calcification,” Ms. Kraemer says.

Researchers tested their hypothesis by inoculating animal models with nanoparticles from human calcified tissues. A second group of models received a diluted inoculation. Blocked arteries were apparent in some animals in both groups 35 days after receiving the dosage.


Related Links:
Mayo Clinic

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
08 May 2007  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
08 May 2007  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
08 May 2007  |   BioResearch